Skip to main content
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
EN
FR
EN
PT
NL
NB
DE
IT
Home
Company Press Releases
Company press releases
Subscribe
Filters
Filters
Refresh
Reset
Icon After
Date
Toggle Visibility
All
Today
This week
This month
Custom date range
From
To
Topic
Toggle Visibility
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 151 - 177 of 177 results
Released
Company
Title
Industry
Topic
24 Aug 2021
22:30 CEST
ERYTECH PHARMA
ERYTECH organise un webinaire, sur eryaspase dans le cancer du pancréas, avec des leaders d'opinion
20103010 Biotechnology
Meetings / events
05 Aug 2021
18:00 CEST
ERYTECH PHARMA
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 juillet 2021
20103010 Biotechnology
Legal
05 Aug 2021
18:00 CEST
ERYTECH PHARMA
Monthly information related to total number of voting rights and shares composing the share capital – July 30, 2021
20103010 Biotechnology
Legal
29 Jul 2021
22:05 CEST
ERYTECH PHARMA
ERYTECH reçoit la désignation Fast Track de la FDA américaine pour eryaspase dans le traitement de la LAL hypersensible
20103010 Biotechnology
Products and services
29 Jul 2021
22:05 CEST
ERYTECH PHARMA
ERYTECH Granted U.S. FDA Fast Track Designation for Eryaspase in Hypersensitive ALL
20103010 Biotechnology
Products and services
27 Jul 2021
07:30 CEST
ERYTECH PHARMA
ERYTECH annonce sa participation à la conférence virtuelle BTIG Biotechnology
20103010 Biotechnology
Meetings / events
27 Jul 2021
07:30 CEST
ERYTECH PHARMA
ERYTECH to Participate in the BTIG Virtual Biotechnology Conference
20103010 Biotechnology
Meetings / events
21 Jul 2021
22:05 CEST
ERYTECH PHARMA
ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients
20103010 Biotechnology
Products and services
21 Jul 2021
22:05 CEST
ERYTECH PHARMA
ERYTECH confirme son intention de déposer une demande de BLA pour eryaspase dans le traitement des patients atteints de LAL hypersensible
20103010 Biotechnology
Products and services
06 Jul 2021
18:00 CEST
ERYTECH PHARMA
Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2021
20103010 Biotechnology
Legal
06 Jul 2021
18:00 CEST
ERYTECH PHARMA
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 Juin 2021
20103010 Biotechnology
Legal
25 Jun 2021
22:30 CEST
ERYTECH PHARMA
Report - Erytech’s Combined Shareholders’ Meeting on June 25, 2021
20103010 Biotechnology
General meeting / Board Meeting
25 Jun 2021
22:30 CEST
ERYTECH PHARMA
COMPTE RENDU - ASSEMBLEE GENERALE MIXTE D’ERYTECH LE 25 JUIN 2021
20103010 Biotechnology
General meeting / Board Meeting
07 Jun 2021
18:00 CEST
ERYTECH PHARMA
Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2021
20103010 Biotechnology
Legal
07 Jun 2021
18:00 CEST
ERYTECH PHARMA
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Mai 2021
20103010 Biotechnology
Legal
26 May 2021
22:30 CEST
ERYTECH PHARMA
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June
20103010 Biotechnology
Meetings / events
26 May 2021
22:30 CEST
ERYTECH PHARMA
ERYTECH participera aux prochaines conférences virtuelles des investisseurs en juin
20103010 Biotechnology
Meetings / events
25 May 2021
22:00 CEST
ERYTECH PHARMA
ASSEMBLEE GENERALE MIXTE D’ERYTECH LE 25 JUIN 2021
20103010 Biotechnology
General meeting / Board Meeting
25 May 2021
22:00 CEST
ERYTECH PHARMA
Erytech’s Combined Shareholders’ Meeting on June 25, 2021
20103010 Biotechnology
General meeting / Board Meeting
07 May 2021
18:00 CEST
ERYTECH PHARMA
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2021
20103010 Biotechnology
Other subject
07 May 2021
18:00 CEST
ERYTECH PHARMA
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2021
20103010 Biotechnology
Other subject
04 May 2021
22:30 CEST
ERYTECH PHARMA
ERYTECH fait le point sur ses activités et publie ses résultats financiers du premier trimestre 2021
20103010 Biotechnology
Income
04 May 2021
22:30 CEST
ERYTECH PHARMA
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021
20103010 Biotechnology
Income
29 Apr 2021
08:30 CEST
ERYTECH PHARMA
ERYTECH Announces $30.0 Million Registered Direct Offering
20103010 Biotechnology
Other financial transaction
29 Apr 2021
08:30 CEST
ERYTECH PHARMA
ERYTECH annonce la levée de 30 millions de dollars dans le cadre d’une registered offering
20103010 Biotechnology
Other financial transaction
29 Apr 2021
01:30 CEST
ERYTECH PHARMA
ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 conference call
20103010 Biotechnology
Other subject
29 Apr 2021
01:30 CEST
ERYTECH PHARMA
ERYTECH annonce sa position de trésorerie au 31 mars 2021 et les détails de participation au webcast de présentation des résultats du T1 2021
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Pagination
«
« First
‹
‹‹
2
3
4
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Home
Markets
Amsterdam
Cash Products
Stocks
AEX index Stocks
AEX ESG Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Quote Vendor Codes
Company regulated news
Latest
Archive
Brussels
Cash products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Bonds
ETFs
Structured Products
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisbon
Cash Products
Stocks
Euronext regulated
Euronext Access
PSI Stocks
Indices
Bonds
Derivative products
Index futures
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Paris
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Equities
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Funds
Directory
ESG Funds
Oslo Mutual Funds
Fixed Income
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Structured Products
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Equity Derivatives
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Commodities
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Resources
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Where to find